Ufp Technologies (UFPT) Cash from Financing Activities (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Cash from Financing Activities came in at -$1.6 million in Q1 2026, up 84.87% YoY from -$875767.9 in Q1 2025, and up 85.12% on a QoQ basis from -$10.9 million in Q4 2025.
Ufp Technologies (UFPT) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Cash from Financing Activities data on file, last reported at -$1.6 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 84.87% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.1 million (down 133.98% YoY) and the FY2025 annual result came in at -$58.2 million, down 138.16% from the prior year.
- Cash from Financing Activities improved to -$1.6 million in Q1 2026, from -$10.9 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $176.8 million in Q3 2024 to a low of -$28.9 million in Q3 2022.
- A 5-year average of $2.2 million and a median of -$10.7 million in 2025 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 3127.1% in 2022, down 721350.0% in 2022.
- Tracing UFPT's Cash from Financing Activities over 5 years: stood at -$20.7 million in 2022, then jumped by 45.74% to -$11.2 million in 2023, then plunged by 102.04% to -$22.7 million in 2024, then jumped by 52.09% to -$10.9 million in 2025, then surged by 85.12% to -$1.6 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.6 million (Q1 2026), -$10.9 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn | -25.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.36 Mn |
| Jun 30, 2026 | -25.36 Mn |
| Mar 31, 2026 | -1.62 Mn |
| Mar 31, 2026 | -1.62 Mn |
| Dec 31, 2025 | -10.88 Mn |
| Dec 31, 2025 | -10.88 Mn |
| Sep 30, 2025 | -17.49 Mn |
| Sep 30, 2025 | -17.49 Mn |
| Jun 30, 2025 | -19.08 Mn |
| Jun 30, 2025 | -19.08 Mn |
| Mar 31, 2025 | -10.70 Mn |
| Mar 31, 2025 | -10.70 Mn |
| Dec 31, 2024 | -22.72 Mn |
| Dec 31, 2024 | -22.72 Mn |
| Sep 30, 2024 | 176.78 Mn |
| Sep 30, 2024 | 176.78 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | -2.72 Mn |
| Mar 31, 2024 | -2.72 Mn |